Global IoT Managed Services Market to Reach $252.9 Billion by 2027

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 7. - Influencer Pool: 3642. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Injectable Drugs Delivery Industry" - https://www.reportlinker.com/p06041877/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

• Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

• Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

• Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

• Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

• Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Injectable Drugs Delivery Market to Reach $852.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Injectable Drugs Delivery estimated at US$437.9 Billion in the year 2020, is projected to reach a revised size of US$852.2 Billion by 2027, growing at aCAGR of 10% over the period 2020-2027. Device, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$172.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Formulation segment is readjusted to a revised 11.3% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $129.6 Billion, While China is Forecast to Grow at 9.5% CAGR
- The Injectable Drugs Delivery market in the U.S. is estimated at US$129.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$149.5 Billion by the year 2027 trailing a CAGR of 9.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 8.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

- Select Competitors (Total 38 Featured) -

• Baxter International, Inc.

• Becton, Dickinson and Company

• Elcam Medical

• Eli Lilly and Company

• Gerresheimer AG

• INJEX Pharma GmbH

• Novartis International AG

• Novo Nordisk A/S

• SCHOTT AG

• Terumo Corporation

• Teva Pharmaceuticals USA, Inc.

• West Pharmaceutical Services, Inc.

Read the full report: https://www.reportlinker.com/p06041877/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Injectable Drugs
Delivery by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Injectable Drugs Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Injectable Drugs
Delivery by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Device by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Device by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Device by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Formulation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Formulation by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Formulation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Home Care by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Home Care by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Home Care by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 16: World Current & Future Analysis for Research
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Research Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Research Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 22: USA Current & Future Analysis for Injectable Drugs
Delivery by Segment - Device and Formulation - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 23: USA Historic Review for Injectable Drugs Delivery by
Segment - Device and Formulation Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: USA 15-Year Perspective for Injectable Drugs Delivery
by Segment - Percentage Breakdown of Value Sales for Device and
Formulation for the Years 2012, 2020 & 2027

Table 25: USA Current & Future Analysis for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 26: USA Historic Review for Injectable Drugs Delivery by
End-Use - Hospitals & Clinics, Home Care, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Injectable Drugs Delivery
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Clinics, Home Care, Research Laboratories and Other End-Uses
for the Years 2012, 2020 & 2027

CANADA
Table 28: Canada Current & Future Analysis for Injectable Drugs
Delivery by Segment - Device and Formulation - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 29: Canada Historic Review for Injectable Drugs Delivery
by Segment - Device and Formulation Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 30: Canada 15-Year Perspective for Injectable Drugs
Delivery by Segment - Percentage Breakdown of Value Sales for
Device and Formulation for the Years 2012, 2020 & 2027

Table 31: Canada Current & Future Analysis for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 32: Canada Historic Review for Injectable Drugs Delivery
by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 33: Canada 15-Year Perspective for Injectable Drugs
Delivery by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care, Research Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 34: Japan Current & Future Analysis for Injectable Drugs
Delivery by Segment - Device and Formulation - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 35: Japan Historic Review for Injectable Drugs Delivery
by Segment - Device and Formulation Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 36: Japan 15-Year Perspective for Injectable Drugs
Delivery by Segment - Percentage Breakdown of Value Sales for
Device and Formulation for the Years 2012, 2020 & 2027

Table 37: Japan Current & Future Analysis for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 38: Japan Historic Review for Injectable Drugs Delivery
by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 39: Japan 15-Year Perspective for Injectable Drugs
Delivery by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care, Research Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 40: China Current & Future Analysis for Injectable Drugs
Delivery by Segment - Device and Formulation - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 41: China Historic Review for Injectable Drugs Delivery
by Segment - Device and Formulation Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 42: China 15-Year Perspective for Injectable Drugs
Delivery by Segment - Percentage Breakdown of Value Sales for
Device and Formulation for the Years 2012, 2020 & 2027

Table 43: China Current & Future Analysis for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 44: China Historic Review for Injectable Drugs Delivery
by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 45: China 15-Year Perspective for Injectable Drugs
Delivery by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care, Research Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

EUROPE
Table 46: Europe Current & Future Analysis for Injectable Drugs
Delivery by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2020 through 2027 and % CAGR

Table 47: Europe Historic Review for Injectable Drugs Delivery
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 48: Europe 15-Year Perspective for Injectable Drugs
Delivery by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 49: Europe Current & Future Analysis for Injectable Drugs
Delivery by Segment - Device and Formulation - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 50: Europe Historic Review for Injectable Drugs Delivery
by Segment - Device and Formulation Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 51: Europe 15-Year Perspective for Injectable Drugs
Delivery by Segment - Percentage Breakdown of Value Sales for
Device and Formulation for the Years 2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 53: Europe Historic Review for Injectable Drugs Delivery
by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 54: Europe 15-Year Perspective for Injectable Drugs
Delivery by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care, Research Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 55: France Current & Future Analysis for Injectable Drugs
Delivery by Segment - Device and Formulation - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 56: France Historic Review for Injectable Drugs Delivery
by Segment - Device and Formulation Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 57: France 15-Year Perspective for Injectable Drugs
Delivery by Segment - Percentage Breakdown of Value Sales for
Device and Formulation for the Years 2012, 2020 & 2027

Table 58: France Current & Future Analysis for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 59: France Historic Review for Injectable Drugs Delivery
by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 60: France 15-Year Perspective for Injectable Drugs
Delivery by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care, Research Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 61: Germany Current & Future Analysis for Injectable
Drugs Delivery by Segment - Device and Formulation -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 62: Germany Historic Review for Injectable Drugs Delivery
by Segment - Device and Formulation Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 63: Germany 15-Year Perspective for Injectable Drugs
Delivery by Segment - Percentage Breakdown of Value Sales for
Device and Formulation for the Years 2012, 2020 & 2027

Table 64: Germany Current & Future Analysis for Injectable
Drugs Delivery by End-Use - Hospitals & Clinics, Home Care,
Research Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 65: Germany Historic Review for Injectable Drugs Delivery
by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 66: Germany 15-Year Perspective for Injectable Drugs
Delivery by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care, Research Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

ITALY
Table 67: Italy Current & Future Analysis for Injectable Drugs
Delivery by Segment - Device and Formulation - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 68: Italy Historic Review for Injectable Drugs Delivery
by Segment - Device and Formulation Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 69: Italy 15-Year Perspective for Injectable Drugs
Delivery by Segment - Percentage Breakdown of Value Sales for
Device and Formulation for the Years 2012, 2020 & 2027

Table 70: Italy Current & Future Analysis for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 71: Italy Historic Review for Injectable Drugs Delivery
by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 72: Italy 15-Year Perspective for Injectable Drugs
Delivery by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care, Research Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 73: UK Current & Future Analysis for Injectable Drugs
Delivery by Segment - Device and Formulation - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 74: UK Historic Review for Injectable Drugs Delivery by
Segment - Device and Formulation Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 75: UK 15-Year Perspective for Injectable Drugs Delivery
by Segment - Percentage Breakdown of Value Sales for Device and
Formulation for the Years 2012, 2020 & 2027

Table 76: UK Current & Future Analysis for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 77: UK Historic Review for Injectable Drugs Delivery by
End-Use - Hospitals & Clinics, Home Care, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 78: UK 15-Year Perspective for Injectable Drugs Delivery
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Clinics, Home Care, Research Laboratories and Other End-Uses
for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 79: Rest of Europe Current & Future Analysis for
Injectable Drugs Delivery by Segment - Device and Formulation -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 80: Rest of Europe Historic Review for Injectable Drugs
Delivery by Segment - Device and Formulation Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 81: Rest of Europe 15-Year Perspective for Injectable
Drugs Delivery by Segment - Percentage Breakdown of Value Sales
for Device and Formulation for the Years 2012, 2020 & 2027

Table 82: Rest of Europe Current & Future Analysis for
Injectable Drugs Delivery by End-Use - Hospitals & Clinics,
Home Care, Research Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 83: Rest of Europe Historic Review for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 84: Rest of Europe 15-Year Perspective for Injectable
Drugs Delivery by End-Use - Percentage Breakdown of Value Sales
for Hospitals & Clinics, Home Care, Research Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 85: Asia-Pacific Current & Future Analysis for Injectable
Drugs Delivery by Segment - Device and Formulation -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 86: Asia-Pacific Historic Review for Injectable Drugs
Delivery by Segment - Device and Formulation Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: Asia-Pacific 15-Year Perspective for Injectable Drugs
Delivery by Segment - Percentage Breakdown of Value Sales for
Device and Formulation for the Years 2012, 2020 & 2027

Table 88: Asia-Pacific Current & Future Analysis for Injectable
Drugs Delivery by End-Use - Hospitals & Clinics, Home Care,
Research Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 89: Asia-Pacific Historic Review for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 90: Asia-Pacific 15-Year Perspective for Injectable Drugs
Delivery by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care, Research Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

REST OF WORLD
Table 91: Rest of World Current & Future Analysis for
Injectable Drugs Delivery by Segment - Device and Formulation -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 92: Rest of World Historic Review for Injectable Drugs
Delivery by Segment - Device and Formulation Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 93: Rest of World 15-Year Perspective for Injectable
Drugs Delivery by Segment - Percentage Breakdown of Value Sales
for Device and Formulation for the Years 2012, 2020 & 2027

Table 94: Rest of World Current & Future Analysis for
Injectable Drugs Delivery by End-Use - Hospitals & Clinics,
Home Care, Research Laboratories and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 95: Rest of World Historic Review for Injectable Drugs
Delivery by End-Use - Hospitals & Clinics, Home Care, Research
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 96: Rest of World 15-Year Perspective for Injectable
Drugs Delivery by End-Use - Percentage Breakdown of Value Sales
for Hospitals & Clinics, Home Care, Research Laboratories and
Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 38
Read the full report: https://www.reportlinker.com/p06041877/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001